Wockhardt looks to roll out 2 vaccines from UK plant in 12 months as part of tie-up with Serum

"Serum has identified two vaccines and we plan to manufacture these products within the next 12 months after exhibit batches and regulatory approval is received," Wockhardt Managing Director and Global CEO Murtaza Khorakiwala said in an analyst call.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/OaiCGeD
via IFTTT